Provided is a phosphorus-containing compound characterized by being a compound represented by the following structure: the compound is a novel immunocyte migration inhibitor. The compound has good hydrophilicity and can be developed into eye drops. The compound has a strong inhibitory ability to immunocyte migration and can relieve the symptoms of most dry-eye patients.